Circadian hormone · Fact sheet

Melatonin

Melatonin is a hormone involved in sleep timing. Evidence is more useful for certain circadian-rhythm problems than for broad claims about treating chronic insomnia, and long-term safety remains less certain.

Not FDA approvedModerate human evidence

What is Melatonin?

The body produces melatonin in response to darkness as part of its internal timing system. Melatonin supplements are regulated differently from prescription medicines in the United States.

Benefits & claims

Falling asleep earlier, reducing jet lag, and improving sleep quality are common goals. Sleep timing, sleep duration, and next-day function are distinct outcomes.

What the evidence supports

  • The delayed-sleep trial found earlier sleep onset and improvement in some sleep-related impairment measures.
  • It does not establish a universal remedy for chronic insomnia or prove long-term safety.
Research areas
  • Delayed sleep-wake phase disorder
  • Jet lag
  • Sleep initiation

Dosage & frequency

Human study context

Melatonin research depends on the sleep disorder, timing, and formulation. No single amount is a validated solution for all insomnia.

Delayed sleep-wake phase disorder trial

Patients with confirmed delayed circadian phase and diagnosed delayed sleep-wake phase disorder

Amount
0.5 mg fast-release melatonin
Frequency
One hour before desired bedtime, at least five nights per week for four weeks
Route studied or labeled
Oral

Combined with behavioral sleep-wake scheduling; not a universal insomnia protocol.

How to read these amounts

An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.

Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences

Formulations, interactions & practical context

Formulation differences

  • Immediate-release and prolonged-release products are different formulations.
  • Timing may matter as much as amount in circadian-rhythm research.

Interactions & precautions

  • NCCIH notes that people taking medicines, including blood thinners, require medical supervision; the cited timing study is not an interaction study.

What is still unresolved

  • Long-term safety in many populations and product-to-product consistency remain uncertain.

Side effects & risks

  • Headache, dizziness, nausea, and daytime sleepiness are reported.
  • An analysis of commercial supplements found substantial variation from labeled melatonin content and serotonin in some products.
  • Long-term effects, particularly in children, are less well understood.

This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.

Clinical research

Moderate human evidence

In a four-week trial, 116 people with verified delayed sleep-wake phase disorder were randomized to melatonin or placebo alongside behavioral scheduling. Results in that selected group do not apply to every sleep complaint.

Studies

Personal experiences

Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.

Explore 3 sourced accounts by reported effect.

Sleep: reported experiences

Negative account · personal report

Nightmares eased after stopping

An author described recurring vivid nightmares that became less troubling after they stopped melatonin.

Reported use in this account

Product
Product described as melatonin
Amount
10 mg, in the author's answer to a question asking milligrams
Frequency
Not specified clearly
Route
Not specified clearly
Duration
Not specified clearly

Other exposures described: Exercise added after stopping melatonin

Dream recall and nightmares were self-reported; changing sleep habits and other causes were not controlled.

Read the original account
Positive account · personal report

Easier sleep with a comfortable morning

A commenter described falling asleep comfortably and waking feeling well after melatonin.

Amount, frequency, route and duration could not be confirmed for this account.

The account provides little health or formulation detail and does not establish how often this response occurs.

Read the original account
Mixed account · personal report

Staying asleep, but with disturbing dreams

A person reported that melatonin gummies helped them stay asleep but were repeatedly followed by unusually vivid and sometimes frightening dreams.

Reported use in this account

Product
Melatonin gummies
Amount
Not specified clearly
Frequency
Not specified clearly
Route
Not specified clearly
Duration
About ten separate uses; calendar duration not stated

This is a selected account with limited formulation and health-history detail. It does not establish how common nightmares are or whether melatonin caused them.

Read the sleep-and-dream account

Approval status

Melatonin has no FDA-approved drug indication for the wellness uses discussed here. Supplement availability is not premarket FDA approval of effectiveness or safety.

Supplement research is not FDA drug approval

Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.

Open questions

  • Long-term safety and developmental effects
  • Which sleep problems benefit most
  • Reliability of individual supplement contents

Summary

It does not establish a universal remedy for chronic insomnia or prove long-term safety.

Sources

Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.

  1. nihNCCIH: melatonin evidence and safety

    Condition-specific evidence, short-term adverse effects, and long-term uncertainties.

  2. pubmedMelatonin plus behavioral scheduling for delayed sleep

    116 randomized participants; four-week follow-up and a selected circadian population.

  3. pubmedMelatonin supplement content and serotonin testing

    Product-analysis study showing label variability; not every current product was tested.

How we assess sources · Suggest a correction